Skip to search.
 STI Up 0.75%

Biogen Inc. (BIIB)

-NasdaqGS
292.50 Down 4.80(1.61%) 2 Sep 04:00 SGT
|After Hours : 296.95 Up 4.45 (1.52%) 2 Sep 07:54 SGT
Add to Portfolio
Prev Close:297.30
Open:292.22
Bid:292.50 x 100
Ask:314.40 x 300
1y Target Est:389.27
Beta:0.411391
Earnings Date:20 Oct - 26 Oct (Est.)
Day's Range:291.26 - 301.98
52wk Range:265.00 - 480.18
Volume:2,498,495
Avg Vol (3m):2,350,720
Market Cap:68.79B
P/E (ttm):19.81
EPS (ttm):14.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 1.61%68.79B
ABTDown 3.80%64.94B
PFEDown 2.67%193.41B

Key Statistics

Forward P/E (1 yr):16.45
P/S (ttm):6.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :15.92
Quarterly EPS Est (Sep-15) :3.92
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback